Apr 09
13
Breast Cancer Drug Sutent Trials Stopped
A drug that was thought to be potentially promising in the treatment of breast cancer because of it’s relative effectiveness in the treatment of other types of cancer called Sutent made by drug giant Pfizer, has been stopped recently in trials. The reason is not that it was totally useless to help treat cancer, but rather that it was no better than the other common chemo drug that is used to treat breast cancer, and the whole point was to see if it could be any more effective than what was already out there.
However, just because the phase 3 trials for Sutent were discontinued in normal breast cancer trials, they are still not counting it out for the treatment of far advanced breast cancer. They are still resuming trials on patients with advanced breast cancer cases, hoping that they may get better results than some of the drugs that are already out there treating those with cases of advanced breast cancer.
The drug is currently being used to treat kidney cancer though, and it quite a successful sales drug at that. It will still be used for that purpose, however, I’m sure Pfizer is disappointed they didn’t have a blockbuster drug for breast cancer as well on their hands since they have already done the research and development necessary for the drug and it’s a successfully marketed and known cancer treatment already.
Just think of the amount of energy we put in to the treatment of cancer. If only we could somehow teach people how to dramatically increase their odds of not getting cancer at all. After all, prevention is the best medicine. Although a lot of cancers are admittedly genetically predisposed to occur in some individuals and admittedly we will probably never eradicate all chances of getting cancer by changing our diet and lifestyle habits, we still can put a huge dent in the numbers on our own by using methods of prevention.
